: eli lilly’s positive results from a alzheimer’s trial seen as ‘potentially very important’

Eli Lilly’s positive trial showed that the drug donanemab ‘significantly slowed cognitive and funct...

May 3, 2023, 6:34 pm

Eli lilly's alzheimer's drug slowed cognitive decline in phase 3 study

Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's Alzheimer's treatment donanemab, which slowed disease progression in the phase 3...

May 3, 2023, 9:56 am

Eli lilly surges after alzheimer's treatment succeeds; biogen also rises

Eli Lilly stock popped Wednesday after the company said its experimental Alzheimer's treatment significantly slowed ...

May 3, 2023, 9:16 am

Eli lilly stock jumps on positive alzheimer's drug phase 3 trial data

The company says a Phase 3 study shows that donanemab 'significantly slowed cognitive and functional de...

May 3, 2023, 6:34 am

Eli lilly stock jumps 4% premarket on news of positive results in late-stage trial of alzheimer's disease treatment

Eli Lilly & Co.'s stock LLY jumped 4% premarket Wednesday, after the company announced positive data from a late-stage trial of its Alzheimer's diseas...

May 3, 2023, 6:14 am

cognitive flexibility is essential to navigating a changing world – new research in mice shows how your brain learns new rules

By Vikaas Sohal, University of California, San Francisco and Kathleen Cho, Inserm Being flexible and learning to adapt when the world changes is somet...

April 27, 2023, 12:05 pm

Volvo cars tech fund invests in driver monitoring startup corractions

CorrActions, an Israeli startup that, among other things, built a driver monitoring system that can understand a driver's ...

April 24, 2023, 11:45 am

Verses closes final tranche of convertible debenture financing for aggregate proceeds of c$7.5m

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — VERSES AI Inc. (NEO:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a ...

March 31, 2023, 10:28 pm

Eli lilly first-generation alzheimer's drug did not slow cognitive decline

Eli Lilly and Co (NYSE:LLY)'s early-generation Alzheimer's drug, solanezumab, did not slow cognitive de...

March 9, 2023, 3:34 am

Verses technologies announces name change to verses ai

VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) — VERSES Technologies Inc. (NEO:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”)...

March 8, 2023, 10:54 pm

Lilly's drug aimed at preventing alzheimer's fails

Eli Lilly & Co. said late Wednesday that a drug aimed at preventing Alzheimer's disease before symptoms start has failed to slow down ...

March 8, 2023, 5:54 pm

Verses closes $5m tranche and announces upsize of convertible debenture financing

VANCOUVER, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) — VERSES Technologies Inc. (NEO:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”)...

March 1, 2023, 1:54 pm

: the perils of ultraprocessed food

A growing body of research links ultraprocessed foods to an array of cancers and, in some cases, to cognitive<...

February 4, 2023, 11:18 am

Cardiovascular disease linked to worse brain health in middle age: research

Cardiovascular diseases such as heart disease and stroke have been associated with an increased risk for cogni...

January 28, 2023, 11:14 pm

Cassava sciences' data once again misunderstood

Cassava Sciences' Simufilam staved off cognitive decline in mild Alzheimer's disease. The market reacte...

January 27, 2023, 11:37 am

Anavex: drug treatments for early alzheimer's disease

Anavex 2-73/blarcamesine at high concentrations in early Alzheimer's disease leads to improvements in cognition and activities of daily living that ar...

January 17, 2023, 5:10 pm

The fda just approved a new alzheimer's drug that's set to be a blockbuster

The new drug, called Leqembi, slowed the rate of cognitive decline in Alzheimer's patients by 27%....

January 6, 2023, 2:21 pm

Fda approves alzheimer's drug that slowed cognitive decline in clinical trial

The FDA's decision comes after clinical trial results indicated that lecanemab slows cognitive decline ...

January 6, 2023, 2:11 pm

Goldman sachs forecast s&p500 to 4000 in 2023

Treat such predictions with care. At the end of 2021 Goldman Sachs forecast for the 2022 S&P500 was 5100.

Not dissing the analysts there, fo...

December 22, 2022, 12:02 am

Anavex life sciences: the little company that did

Anavex's 2-73/blarcamesine produced significant reductions in cognitive decline in early Alzheimer's di...

December 6, 2022, 12:51 pm